See All Slides - tctmd.com

Slides

Presentation TCT 2019

Case #5: Unexpected Mechanism of ISR Revealed by OCT

Presenter: Marc Feldman

September 26, 2019

Presentation TCT 2019

Value of Assessing Microvascular Function: Core Findings From CorMica and Other Studies

Presenter: Tom Ford

September 26, 2019

Presentation TCT 2019

Neurovascular Team: IC Perspective

Presenter: Lawrence Garcia

September 26, 2019

Featured Technological Trends - Wearable Device for Continuous, Noninvasive Monitoring of Vascular Access Health and Fluid Status in Hemodialysis Patients (GraftWorx)

Presentation TCT 2019

Wearable Device for Continuous, Noninvasive Monitoring of Vascular Access Health and Fluid Status in Hemodialysis Patients (GraftWorx)

Presenter: William Gray

September 26, 2019

Presentation TCT 2019

Utility of Coronary Physiology Assessment in the Asymptomatic Patient

Presenter: Stephane Fournier

September 26, 2019

Presentation TCT 2019

Infarct Size Reduction: From the First FDA-Approved Therapy (SSO2) to Novel Approaches

Presenter: Gregg Stone

September 26, 2019

Presentation TCT 2019

Portugal Presents: Percutaneous Treatment of Aortic Dissection and Rupture During a Transcatheter Aortic Valve Implantation Procedure

Presenter: Pedro de Araujo Goncalves

September 26, 2019

Presentation TCT 2019

Presentation of Case Study

Presenter: Andrew Klein

September 26, 2019

Presentation TCT 2019

Drug-Eluting Technologies for SFA Disease: Industry’s Perspective and a Pathway Forward

Presenter: Ian Meredith AM

September 26, 2019

Presentation TCT 2019

Is Paravalvular Regurgitation Still a Worrisome Complication With New-Generation TAVR Systems?

Presenter: Philippe Pibarot

September 26, 2019

Advertisement

Slides

Case #5: Unexpected Mechanism of ISR Revealed by OCT

Value of Assessing Microvascular Function: Core Findings From CorMica and Other Studies

Neurovascular Team: IC Perspective

Wearable Device for Continuous, Noninvasive Monitoring of Vascular Access Health and Fluid Status in Hemodialysis Patients (GraftWorx)

Utility of Coronary Physiology Assessment in the Asymptomatic Patient

Infarct Size Reduction: From the First FDA-Approved Therapy (SSO2) to Novel Approaches

Portugal Presents: Percutaneous Treatment of Aortic Dissection and Rupture During a Transcatheter Aortic Valve Implantation Procedure

Presentation of Case Study

Drug-Eluting Technologies for SFA Disease: Industry’s Perspective and a Pathway Forward

Is Paravalvular Regurgitation Still a Worrisome Complication With New-Generation TAVR Systems?

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content